Medicinal Cannabis Investment Market Update
Sydney, Sep 17, 2019 AEST (ABN Newswire) - BPH Energy Ltd (
ASX:BPH) is pleased to provide market update in relation to developments for its Medicinal Cannabis investment Patagonia Genetics.
Patagonia Genetics purchases first 1,300ltrs of Wonderland Agronutrients products to send samples to major licensed producers and grow shops internationally.
BACKGROUND
Patagonia Genetics has secured the exclusive worldwide distribution rights (excluding Chile & Argentina) to Chile's leading cannabis fertilizer and biostimulant range, Wonderland Agronutrients. The range includes a 'Home Grow' and an 'Algae based Biostimulant' products.
In less than 3 years Wonderland Agronutrients has become one of the leading Chilean brand of cannabis oriented fertilisers in this highly competitive market, surpassed only by the largest international brands, such as Advanced Nutrients, Bio Biz, Grotek, Atami and Hessi, all of which have been in the market for around a decade.
Wonderland has penetrated over 90% of specialized retail outlets in Chile (over 1,500 outlets) and continues to grow its share of market with its complete array of products for all needs and stages of the plant.
HOME GROW RANGE
The Wonderland 'Home Grow' range is targeted towards the home cultivation markets and supports all stages of the plant life cycle, comprising of:-
Tripack - A three stage biostimulating fertilizer composed of:
- Big Vegeta - Stimulates development & growth during vegetative stage;
- Sweet Angel - Promotes metabolism during pre-flowering stage when plants demand most energy.
- K-Bloom - Stimulates flowering favouring absorption of water and nutrients improving size and quality of buds.
Fungi - Copper based fertilizing product that prevents and attacks all type of fungi & bacteria.
Outpest - Organic pesticide that eliminates most common pests including greenflies, whiteflies, thrips and the devastating spider mites.
Raizer - Root stimulant that also improves physical, chemical and biological properties of soil.
ALGAE BASED BIOMSTIMULANT
The Wonderland 'Algae based Biostimulants' range is formulated specially for Patagonia Genetics.
This is a three stage treatment that caters to the specific needs of three basic stages of the plants: rooting, vegetative and flowering.
All are concentrated marine algae (Ascophyllum nodosum) based extracts that stimulate the metabolism and favour the fitorregulation of the plants.
Naturally wild growing algae is sourced from Southern coastlines and harvested by craftsmen using traditional/ environmentally friendly methods.
Whilst the algae based product is considered relatively new and experimental, it has been having extremely encouraging results, with some recently shared on Wonderland's social media.
https://www.instagram.com/wonderlandagronutrients/
INITIAL ORDERS PLACED WITH WONDERLAND AGRONUTRIENTS
Patagonia Genetics has recently made purchases of both of the Wonderland product ranges, being the 'Home Grow' and the 'Algae based Biostimulants' exceeding 1,300ltrs in order to send samples to major licensed producers and grow shops internationally who have shown interest.
Initial modelling completed by Patagonia Genetics shows potential for margins of between 60-80% on the Wonderland Agronutrients distribution deal. The financial impact of this development is not material. Further information on sales progress will be provided in due course.
To view more information, please visit:
https://abnnewswire.net/lnk/CQG93G6R
About BPH Energy Limited
BPH Energy Limited (ASX:BPH) is an Australian Securities Exchange listed company developing biomedical research and technologies within Australian Universities and Hospital Institutes.
The company provides early stage funding, project management and commercialisation strategies for a direct collaboration, a spin out company or to secure a license.
BPH provides funding for commercial strategies for proof of concept, research and product development, whilst the institutional partner provides infrastructure and the core scientific expertise.
BPH currently partners with several academic institutions including The Harry Perkins Institute for Medical Research and Swinburne University of Technology (SUT).
| ||
|
